These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8489313)

  • 21. Use of sorbent columns and haemofiltration in fulminant hepatic failure.
    Hughes RD; Williams R
    Blood Purif; 1993; 11(3):163-9. PubMed ID: 8280438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) model.
    Sheil AG; Sun J; Mears DC; Waring M; Woodman K; Johnston B; Horvat M; Watson J; Koutalistras N; Wang L
    Int J Artif Organs; 1998 Jan; 21(1):43-8. PubMed ID: 9554825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte culture systems for artificial liver support: implications for critical care medicine (bioartificial liver support).
    Nyberg SL; Shatford RA; Hu WS; Payne WD; Cerra FB
    Crit Care Med; 1992 Aug; 20(8):1157-68. PubMed ID: 1643896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of severe liver failure with a bioartificial liver.
    Chen SC; Mullon C; Kahaku E; Watanabe F; Hewitt W; Eguchi S; Middleton Y; Arkadopoulos N; Rozga J; Solomon B; Demetriou AA
    Ann N Y Acad Sci; 1997 Dec; 831():350-60. PubMed ID: 9616727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hybrid (bioartificial) systems for liver support. History and current developments].
    Morsiani E
    Ann Ital Chir; 2000; 71(3):311-8. PubMed ID: 11014010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver support systems: the low clearance of model hepatic excretory anions by charcoal hemoperfusion.
    Hew JT; Hart FE; Willson RA
    Gastroenterology; 1978 Apr; 74(4):661-3. PubMed ID: 631502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver assist systems: state of the art.
    Arkadopoulos N; Detry O; Rozga J; Demetriou AA
    Int J Artif Organs; 1998 Dec; 21(12):781-7. PubMed ID: 9988354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute hepatic insufficiency and the artificial liver].
    Sandu L
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1981; 30(2):145-58. PubMed ID: 6454910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of extracorporeal liver support systems and clinical results.
    McLaughlin BE; Tosone CM; Custer LM; Mullon C
    Ann N Y Acad Sci; 1999 Jun; 875():310-25. PubMed ID: 10415578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
    Sielaff TD; Hu MY; Amiot B; Rollins MD; Rao S; McGuire B; Bloomer JR; Hu WS; Cerra FB
    J Surg Res; 1995 Jul; 59(1):179-84. PubMed ID: 7630125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A hybrid bioartificial liver composed of multiplated hepatocyte monolayers.
    Uchino J; Tsuburaya T; Kumagai F; Hase T; Hamada T; Komai T; Funatsu A; Hashimura E; Nakamura K; Kon T
    ASAIO Trans; 1988; 34(4):972-7. PubMed ID: 3219260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum bile acids in patients with liver failure supported with a bioartificial liver.
    Pazzi P; Morsiani E; Vilei MT; Granato A; Rozga J; Demetriou AA; Muraca M
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1547-54. PubMed ID: 12182755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Nafamostat Mesilate for improving the performance of a bioartificial liver using porcine hepatocytes.
    Fujioka H; Eguchi S; Sugiyama N; Kawazoe Y; Kawashita Y; Kamohara Y; Azuma T; Furui J; Kanematsu T
    Int J Artif Organs; 1999 Jul; 22(7):505-10. PubMed ID: 10493559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial liver support: requirements and approaches.
    Chang TM
    Int J Artif Organs; 1983 Jul; 6(4):178-82. PubMed ID: 6414953
    [No Abstract]   [Full Text] [Related]  

  • 35. [An artificial liver on its way to clinical reality?].
    Thasler WE; Koebe HG; Pahernik SA; Schildberg FW
    Zentralbl Chir; 1995; 120(8):614-23. PubMed ID: 7571893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of double-filtration plasmapheretic cross-circulation with a high-permeability membrane using canine harvested liver in porcine fulminant hepatic failure model.
    Ishizawa Y; Totsuka E; Umehara M; Nishimura A; Ono H; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2344-8. PubMed ID: 15561244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial liver support systems.
    George J
    J Assoc Physicians India; 2004 Sep; 52():719-22. PubMed ID: 15839451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acid absorption of plasmapheresed serum by resins and charcoal.
    Alp MH; Lipschitz E
    Int J Artif Organs; 1985 May; 8(3):141-6. PubMed ID: 4030132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a hybrid artificial liver using polyurethane foam/hepatocyte spheroid culture in a preclinical pig experiment.
    Nakazawa K; Ijima H; Fukuda J; Sakiyama R; Yamashita Y; Shimada M; Shirabe K; Tsujita E; Sugimachi K; Funatsu K
    Int J Artif Organs; 2002 Jan; 25(1):51-60. PubMed ID: 11853072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyacrylonitrile membrane interposition between a xenograft and an animal in fulminant liver failure. The concept of xenohemodiafiltration.
    Argibay PF; Vazquez JC; Hyon SH; Garcia H; Nuñez F
    ASAIO J; 1996; 42(5):M411-6. PubMed ID: 8944918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.